Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Washington [US], August 1 (ANI): According to a new study led by Vanderbilt University Medical Center, a biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients.
Washington [US], July 27 (ANI): A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according to a new study led by Vanderbilt University Medical Center.
Washington [US], July 24 (ANI): Some antibiotics appear to be effective against a form of skin cancer known as melanoma, according to the findings of a new study.
Madrid [Spain], July 18 (ANI): Scientists, during a recent study discovered combining BRAF oncogene inhibitors and chemotherapy, is a very effective strategy for fighting metastatic melanoma, which is the leading cause of death from skin cancer around the globe.
Madrid [Spain], July 13 (ANI): During a recent study, researchers found that combining BRAF oncogene inhibitors and chemotherapy is a very effective strategy for fighting metastatic melanoma, which is the leading cause of death from skin cancer around the globe.
Vancouver [Canada], June 1 (ANI): In breakthrough research, a new discovery in Ewing sarcoma, an aggressive and often fatal childhood cancer, has uncovered the potential to prevent cancer cells from spreading beyond their primary tumour site.
Richmond (Virginia) [United States], May 1 (ANI): Through T cell engineering, researchers at Virginia Commonwealth University Massey Cancer Center show that it's possible to arrest tumour growth for a variety of cancers and squash the spread of cancer to other tissues.
Washington [US], April 8 (ANI): Cancer doctors may soon have a new tool for treating melanoma and other types of cancer, thanks to work being done by researchers at the University of Colorado Cancer Center who claimed to have found a drug that can reduce inflammation and the resultant tumour
Washington [US], February 21 (ANI): A team of scientists from Australia published a study in the journal Clinical Cancer Research that shows their new discovery of a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.
Washington [US], February 20 (ANI): Researchers during a recent study proved successful in developing a prototype test that will be able to help in identifying whether immunotherapy is beneficial for patients suffering from deadly metastasised melanoma.